Catalan Institute of Oncology (ICO)
If you are the contact person for this centre and you wish to make any changes, please contact us.
Research technician at the Girona Cancer Epidemiology and Registry Unit of the Catalan Institute of Oncology-Oncology Master Plan
Head of the Hereditary Cancer Research Group at the Catalan Institute of Oncology-IDIBELL
Deputy Head of the Tobacco Control Unit at the Catalan Institute of Oncology and lecturer in the Department of Nursing, Public Health, Mental Health and Maternal and Child Health at the University of Barcelona
Medical Oncologist at the Catalan Institute of Oncology (ICO
Assistant doctor of medical oncology at the Catalan Institute of Oncology and at the Girona University Hospital Doctor Josep Trueta
Director of Epidemiology, Prevention and Cancer Control at the Catalan Institute of Oncology and Director of the WHO Collaborating Centre for Tobacco Control at the Catalan Institute of Oncology
Head of the Haematology Department at ICO Badalona
Principal investigator, Digital Health Programme ICOnnecta't, and member of the Group of Psycho-oncology and Digital Health at IDIBELL
Epidemiologist at the Catalan Institute of Oncology and professor of medicine at the University of Girona
Head of Medical Oncology at the Catalan Institute of Oncology (ICO), head of the Colorectal Cancer Research Group, Oncobell programme (IDIBELL) and associate professor of Medicine at the University of Barcelona
Principal Investigator of the Nutrition and Cancer Unit of the Catalan Institute of Oncology (ICO) and the Bellvitge Biomedical Research Institute (IDIBELL)
Emeritus researcher at the Catalan Institute of Oncology (ICO), senior researcher at the Bellvitge Biomedical Research Institute (IDIBELL) and lecturer in the Faculty of Health Sciences at the Universitat Oberta de Catalunya (UOC)
In an interview on TV3's Els Matins, the Catalan government's health minister Josep Maria Argimon explained that they are preparing a regulation to ban smoking on bar terraces and make them "smoke-free spaces". They are also considering adding canopies and the entrances and exits of schools to the ban.
In the United States, the human papillomavirus vaccine began to be recommended in 2006 for girls aged 9-26 years. A study published in the journal JAMA Health Forum concludes that the campaign significantly reduced the risk of HPV infection in vaccinated women. In addition, herd immunity reduced the likelihood of infection in unvaccinated women.
A study published in The Lancet finds that 44.4% of cancer deaths worldwide are due to preventable risk factors, especially smoking, alcohol consumption and being overweight.